Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 13, 2020 - Issue
Submit an article Journal homepage
176
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma

Nora Drick1 Department of Respiratory Medicine, Hannover Medical School, Hannover, GermanyView further author information
,
Katrin Milger2 Department of Internal Medicine V, Ludwig-Maximilians University of Munich (LMU), Munich, GermanyORCID Iconhttps://orcid.org/0000-0003-2914-8773View further author information
ORCID Icon,
Benjamin Seeliger1 Department of Respiratory Medicine, Hannover Medical School, Hannover, GermanyORCID Iconhttps://orcid.org/0000-0001-7373-752XView further author information
ORCID Icon,
Jan Fuge1 Department of Respiratory Medicine, Hannover Medical School, Hannover, GermanyORCID Iconhttps://orcid.org/0000-0003-2926-3608View further author information
ORCID Icon,
Stephanie Korn3 Pulmonary Department, Mainz University Hospital, Mainz, GermanyView further author information
,
Roland Buhl3 Pulmonary Department, Mainz University Hospital, Mainz, GermanyView further author information
,
Maren Schuhmann4 Department of Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, GermanyView further author information
,
Felix Herth4 Department of Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, GermanyORCID Iconhttps://orcid.org/0000-0002-7638-2506View further author information
ORCID Icon,
Benjamin Kendziora5 Allergy-Centre-Charité, Charité – Universitätsmedizin Berlin, Berlin, GermanyORCID Iconhttps://orcid.org/0000-0002-5234-5380View further author information
ORCID Icon,
Juergen Behr2 Department of Internal Medicine V, Ludwig-Maximilians University of Munich (LMU), Munich, GermanyView further author information
,
Nikolaus Kneidinger2 Department of Internal Medicine V, Ludwig-Maximilians University of Munich (LMU), Munich, GermanyORCID Iconhttps://orcid.org/0000-0001-7583-0453View further author information
ORCID Icon,
Karl-Christian Bergmann5 Allergy-Centre-Charité, Charité – Universitätsmedizin Berlin, Berlin, GermanyView further author information
,
Christian Taube6 Department of Pulmonary Medicine, University Hospital Essen – Ruhrlandklinik, Essen, GermanyView further author information
,
Tobias Welte1 Department of Respiratory Medicine, Hannover Medical School, Hannover, GermanyORCID Iconhttps://orcid.org/0000-0002-9947-7356View further author information
ORCID Icon &
Hendrik Suhling1 Department of Respiratory Medicine, Hannover Medical School, Hannover, GermanyCorrespondence[email protected]
View further author information
 show all
Pages 605-614 | Published online: 11 Nov 2020

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Pia Maria Plank, Christopher Alexander Hinze, Victoria Campbell, Stefanie Konwert, Tobias Welte, Nora Drick, Moritz Z Kayser, Hendrik Suhling & Jan Fuge. (2023) Relationship Between the Response to Antibody Therapy and Symptoms of Depression and Anxiety Disorders in Patients with Severe Asthma. Journal of Asthma and Allergy 16, pages 421-431.
Read now
Takanori Numata, Jun Araya, Keitaro Okuda, Hanae Miyagawa, Shunsuke Minagawa, Takeo Ishikawa, Hiromichi Hara & Kazuyoshi Kuwano. (2022) Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study. Journal of Asthma and Allergy 15, pages 1731-1741.
Read now
Ana Gómez-Bastero Fernández, Juan Francisco Medina Gallardo, Julio Delgado Romero, Auxiliadora Romero Falcón, Cristina Benito Bernáldez, Javier Gallego Borrego & Francisco Javier Álvarez-Gutiérrez. (2022) Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma. Journal of Asthma and Allergy 15, pages 727-735.
Read now
Agamemnon Bakakos, Nikoletta Rovina, Stelios Loukides & Petros Bakakos. (2022) Biologics in severe asthma: Outcomes in clinical trials-Similarities and differences. Expert Opinion on Biological Therapy 22:7, pages 855-870.
Read now
Takanori Numata, Jun Araya, Hanae Miyagawa, Keitaro Okuda, Yu Fujita, Hirofumi Utsumi, Daisuke Takekoshi, Mitsuo Hashimoto, Shunsuke Minagawa, Takeo Ishikawa, Hiromichi Hara & Kazuyoshi Kuwano. (2021) Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study. Journal of Asthma and Allergy 14, pages 609-618.
Read now

Articles from other publishers (16)

Katsuyoshi Tomomatsu, Hirotaka Yasuba, Takashi Ishiguro, Shiro Imokawa, Johsuke Hara, Seiko Soeda, Norihiro Harada, Naomi Tsurikisawa, Naohiro Oda, Shigeki Katoh, Takanori Numata, Yasuteru Sugino, Mitsuhiro Yamada, Mitsuhiro Kamimura, Takeshi Terashima, Naoki Okada, Jun Tanaka, Tsuyoshi Oguma & Koichiro Asano. (2023) Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis. Scientific Reports 13:1.
Crossref
Katrin MilgerStephanie Korn, Claudia Feder, Jan Fuge, Andreas Mühle, Wolfgang Schütte, Dirk Skowasch, Hartmut Timmermann & Hendrik Suhling. (2023) Kriterien zur Evaluation des Ansprechens auf Biologika bei schwerem Asthma – der Biologics Asthma Response Score (BARS). Pneumologie 77:04, pages 220-232.
Crossref
Marco Caminati, Alessandro Marcon, Gabriella Guarnieri, Jessica Miotti, Diego Bagnasco, Giovanna Elisiana Carpagnano, Girolamo Pelaia, Rachele Vaia, Matteo Maule, Andrea Vianello & Gianenrico Senna. (2023) Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective. Journal of Clinical Medicine 12:5, pages 1836.
Crossref
Mizuki Yamada, Kohei Matsuoka, Mitsuo Sato & Kazuhide Sato. (2023) Recent Advances in Localized Immunomodulation Technology: Application of NIR-PIT toward Clinical Control of the Local Immune System. Pharmaceutics 15:2, pages 561.
Crossref
Laura J. Walsh, Deborah Casey, Punitha Vairamani, Fiona Arnott, Barry J. Plant & Desmond M. Murphy. (2023) Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab. Frontiers in Allergy 3.
Crossref
Hiroyuki Nagase, Maho Suzukawa, Keiji Oishi & Kazuto Matsunaga. (2023) Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy. Allergology International 72:1, pages 11-23.
Crossref
John Politis & Philip G. Bardin. (2022) Switching Biological Therapies in Adults with Severe Asthma: What Are the Dilemmas and Is It Worthwhile?. Annals of the American Thoracic Society 19:12, pages 1965-1970.
Crossref
Karl-Christian Bergmann, Jörg-Wilhelm Oestmann, Jean Bousquet & Torsten Zuberbier. (2022) Successful simultaneous targeting of IgE and IL-5 in a severe asthmatic patient selected for lung transplantation. World Allergy Organization Journal 15:8, pages 100669.
Crossref
Shoko Isoyama, Nobuhisa Ishikawa, Kosuke Hamai, Mirai Matsumura, Hiroki Kobayashi, Akio Nomura, Sayaka Ueno, Takuya Tanimoto, Hiroyuki Maeda, Hiroshi Iwamoto & Noboru Hattori. (2022) Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study. Internal Medicine 61:11, pages 1663-1671.
Crossref
Rory Chan, Kirsten Stewart, Rasads Misirovs & Brian J. Lipworth. (2022) Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma. The Journal of Allergy and Clinical Immunology: In Practice 10:6, pages 1497-1505.
Crossref
Adel H. Mansur. (2022) Effect of benralizumab in a patient with uncontrolled severe eosinophilic asthma and comorbid chronic rhinosinusitis with nasal polyps refractory to mepolizumab treatment. Respiratory Medicine Case Reports 35, pages 101559.
Crossref
Margarete Olivier, Florian Stehling, Mathis Steindor & Christian Taube. (2021) Allergien und schweres AsthmaAllergies and severe asthma. Der Pneumologe 18:6, pages 366-377.
Crossref
Agamemnon Bakakos, Nikoleta Rovina & Petros Bakakos. (2021) Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy. International Journal of Molecular Sciences 22:8, pages 3969.
Crossref
Gwan Ui HongEun Young HongMyung-Hee Chung & Jai Youl Ro. (2021) Hwang Chan Go, a Mixture of Onion, Garlic and Wild Rice Extracts, Reduces the Release of Mediators from Mast Cell in Ovalbumin-Induced Allergic Lung in Mice. Food Supplements and Biomaterials for Health 1:4.
Crossref
Laura Mattei, Carey M. Suehs, Khuder Alagha, Arnaud Bourdin, Christophe Brousse, Jeremy Charriot, Gilles Devouassoux, Stephanie Fry, Laurent Guilleminault, Marion Gouitaa, Camille Taille, Pascal Chanez & Laurie Pahus. (2021) Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study. Therapeutic Advances in Respiratory Disease 15, pages 175346662110497.
Crossref
John Davison & Simon Doe. (2021) A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment. Respiratory Medicine Case Reports 34, pages 101557.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.